Frontiers in Drug Design and Discovery

Volume 3

eBook: US $44 Special Offer (PDF + Printed Copy): US $321
Printed Copy: US $299
Library License: US $176
ISSN: 1574-0889 (Print)
ISSN: 2212-1064 (Online)
ISBN: 978-1-60805-671-2 (Print)
ISBN: 978-1-60805-201-1 (Online)
Year of Publication: 2007
DOI: 10.2174/97816080520111070301


Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The book series should prove to be of interest to all the pharmaceutical scientists involved in research in drug design and discovery. Each volume is devoted to the major advances in drug design and discovery.

The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

The book series is available in print, online and CD editions.

Indexed in

EMBASE, Scopus, Genamics JournalSeek

Indexed in: Scopus, EMBASE, Scilit, EBSCO, Ulrich's Periodicals Directory.

Editorial: Structure-Based Drug Design in the 21st Century

- Pp. i-iii (3)
Atta-ur-Rahman, M. Iqbal Choudhary, Gary W. Caldwell, Mark R. Player
View Abstract

Alpha-Helix Mimetics: Progress Toward Effective Modulation of Protein-Protein Complexes

- Pp. 5-44 (40)
Daniel J. Parks, Mark R. Player
View Abstract

Structures of HIV Protease Guide Inhibitor Design to Overcome Drug Resistance

- Pp. 45-62 (18)
Irene T. Weber, Andrey Y. Kovalevsky, Robert W. Harrison
View Abstract

Structure and Function of G Protein-Coupled Receptors Studied Using Sequence Analysis, Molecular Modeling and Receptor Engineeri

- Pp. 63-79 (17)
Stefano Costanzi, Andrei A. Ivanov, Irina G. Tikhonova, Kenneth A. Jacobson
View Abstract

Virtual Docking: How Are We Doing And How Can We Improve?

- Pp. 81-103 (23)
Renee L. DesJarlais, Maxwell D. Cummings, Alan C. Gibbs
View Abstract

Fragment-Based Lead Discovery by NMR

- Pp. 105-119 (15)
Markus Schade
View Abstract

Targeting Drug Resistant Mutations Using Novel Binding Interactions - Lessons Learned from Abl-T315I and their Implications in D

- Pp. 121-144 (24)
Glen Noronha, Jianguo Cao, Chun Chow, Elena Dneprovskaia, Linda Hwang, Dan Lohse, Chi Ching Mak, Andrew McPherson, Richard M. Fine, Xinshan Kang, Boris Klebansky, Moorthy S.S. Palanki, Ved P. Pathak, Joel Renick, Richard Soll, Binqi Zeng
View Abstract

Recent Advances in the Structure-Guided Design of Protein Kinase Inhibitors

- Pp. 145-170 (26)
Campbell McInnes
View Abstract

Fragment-Based Approaches to Lead Discovery

- Pp. 171-202 (32)
Daniel F. Wyss, Hugh L. Eaton
View Abstract

Recent Advances in Structure-Based Design of Nuclear Hormone Receptors

- Pp. 203-224 (22)
Ronald L. Magolda, William S. Somers, Rayomand J. Unwalla
View Abstract

Structure-Based Drug Development Against Malaria

- Pp. 225-255 (31)
Kathrin Buchholz, Boniface Mwongela Mailu, R. Heiner Schirmer, Katja Becker
View Abstract

Virtual Screening of Compound Libraries Using In silico Three Dimensional Pharmacophores to Aid the Discovery and Design of Anti

- Pp. 257-292 (36)
Apurba K. Bhattacharjee
View Abstract

DNA Helicases Implicated in Chromosomal Instability Disorders as Targets for the Discovery of Novel Anti-Cancer Agents

- Pp. 293-316 (24)
Rigu Gupta, Robert M. Brosh
View Abstract

Scoring Functions for Virtual Screening

- Pp. 317-379 (63)
Francesca Spyrakis, Glen E. Kellogg, Alessio Amadasi, Pietro Cozzini
View Abstract

Reactivators of Tabun-Inhibited Acetylcholinesterase: Structure-Biological Activity Relationship

- Pp. 381-394 (14)
Kamil Kuca, Daniel Jun, Kamil Musilek, Jiri Bajgar
View Abstract

Peptide Diversity in Drug Discovery

- Pp. 395-432 (38)
Marian P. Brennan, Dermot Cox, Anthony J. Chubb
View Abstract

Protection of Neurovascular Injury by Vasoprotective Agents: A Novel Therapeutic Strategy for Ischemic Brain Edema

- Pp. 433-454 (22)
Feng Han, Norifumi Shioda, Yasufumi Shirasaki, Kohji Fukunaga
View Abstract

Protein Flexibility and Mobility in Structure-Based Drug Design

- Pp. 455-476 (22)
Aqeel Ahmed, Sina Kazemi, Holger Gohlke
View Abstract

Structure-Based Virtual Screening

- Pp. 477-502 (26)
György M. Keseru
View Abstract

Computer-Aided Engineering of GPCRS and Its Application to Drug Discovery

- Pp. 503-523 (21)
Antonio Lavecchia
View Abstract

Antibody-Drug Conjugates in Targeted Therapy for Cancer

- Pp. 525-537 (13)
Ruoping Tang, Simy Cohen, Ollivier Legrand, Jean-Pierre Marie
View Abstract

Structure-Activity Relationships in Peptides: from Modelling to Rational Drug Design

- Pp. 539-558 (20)
Ettore Benedetti, Carlo Pedone, Michele Saviano
View Abstract

Rational Design Strategies for the Development of Synthetic Quinoline and Acridine Based Antimalarials

- Pp. 559-609 (51)
Michael J. Dascombe, Michael G.B. Drew, Philip G. Evans, Fyaz M.D. Ismail
View Abstract


- Pp. 611-617 (7)
Atta-ur-Rahman, Gary W. Caldwell, M. Iqbal Choudhary, Mark R. Player
Download Free

Subject Index to Volume 3

- Pp. 619-634 (16)
Atta-ur-Rahman, Gary W. Caldwell, M. Iqbal Choudhary, Mark R. Player
Download Free